These mice harbor the miR-17-92 transgene targeted to the Gt(ROSA)26Sor locus. miR-17-92 transgenic mice allow the cre-inducible expression of the human miR-17-92 cluster which has been associated with lymphomas and other cancers, autoimmune defects, and altered expression of tumor suppressor and pro-apoptotic genes.
Klaus Rajewsky, Max Delbruck Centre for Molecular Medicine
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Conditional ready (e.g. floxed), Reporter, Humanized sequence, No functional change) | Gt(ROSA)26Sor | gene trap ROSA 26, Philippe Soriano |
Mice homozygous for the "miR-17-92 transgene" conditional allele are viable and fertile, with a loxP-flanked Neo-STOP cassette preventing transcription of the downstream bicistronic sequences (human miR-17-92 cluster (encoding the precursor of seven miRNA molecules; miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-20a, miR-19b and miR-92) and EGFP). When bred to mice that express Cre recombinase, the resulting offspring will have the STOP cassette deleted in the cre-expressing tissue(s); resulting in expression of the human miR-17-92 cluster. Because the synthetic CAG promoter driven miR-17-92 transgene was targeted for insertion into the Gt(ROSA)26Sor locus, expression of the transgene is determined by which tissue(s) express Cre recombinase. EGFP fluorescence, however, is not reported following exposure to Cre recombinase (presumably due to RNaseIII excision of the stem-loop structures encoding individual miRNA destabilizing the EGFP portion of the primary transcript). These miR-17-92 transgenic mice allow inducible expression of the human miR-17-92 cluster that has been associated with lymphomas and other cancers, autoimmune defects, and altered expression of tumor suppressor and pro-apoptotic genes.
The "miR-17-92 transgene" was designed with (from 5' to 3') a synthetic CAG promoter, a loxP-flanked Neo-STOP cassette, a genomic DNA fragment encoding the human miR-17-92 cluster (encoding the precursor of seven miRNA molecules; miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-20a, miR-19b and miR-92), a frt-flanked internal ribosomal entry site-enhanced green fluorescent protein (IRES-EGFP), and polyadenylation signal. This transgene was inserted between exons 1 and 2 of the Gt(ROSA)26Sor locus via electroporation into C57BL/6-derived Bruce-4 embryonic stem (ES) cells. Correctly targeted ES cells were selected and chimeric animals were bred to generate mutant mice. These "miR-17-92 transgenic" mice were maintained on a C57BL/6 genetic background as a homozygous colony for many generations (see SNP note below). Upon arrival at The Jackson Laboratory, mice were bred with C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 2 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Expressed Gene | Mirn17-92, microRNA cluster 17-92, |
Site of Expression | When bred to mice that express Cre recombinase, the resulting offspring will have the STOP cassette deleted in the cre-expressing tissue(s); resulting in expression of the human miR-17-92 cluster. EGFP fluorescence, however, is not reported following exposure to Cre recombinase. |
Allele Name | targeted mutation 3, Klaus Rajewsky |
---|---|
Allele Type | Targeted (Conditional ready (e.g. floxed), Reporter, Humanized sequence, No functional change) |
Allele Synonym(s) | Gt(ROSA)26Sortm3(CAG-MIRN17-92,-EGFP)Rsky; Gt(ROSA)26Sortm3Rsky; miR-17-92TG; miRNA-17-92OE |
Gene Symbol and Name | Gt(ROSA)26Sor, gene trap ROSA 26, Philippe Soriano |
Gene Synonym(s) | |
Promoter | CAG, CMV-IE enhancer/chicken beta-actin/rabbit beta-globin hybrid promoter, |
Expressed Gene | GFP, Green Fluorescent Protein, |
Expressed Gene | Mirn17-92, microRNA cluster 17-92, |
Site of Expression | When bred to mice that express Cre recombinase, the resulting offspring will have the STOP cassette deleted in the cre-expressing tissue(s); resulting in expression of the human miR-17-92 cluster. EGFP fluorescence, however, is not reported following exposure to Cre recombinase. |
Strain of Origin | B6.Cg-Thy1a |
Chromosome | 6 |
Molecular Note | A cassette containing the chicken beta actin promoter CAG driving the expression of a floxed neo-STOP cassette followed by cDNA encoding human MIRN 17, 18a, 19a, 20a, 19b and 92 plus an frt-flanked IRES-EGFP cassette and a poly-adenylation site were inserted into the ROSA locus. This allele is also a knockin allele that allows for expression of the human MIRNs contained within it following the cre-mediated removal of the neo-STOP cassette. |
Mutations Made By | Klaus Rajewsky, Max Delbruck Centre for Molecular Medicine |
When maintaining a live colony, homozygous mice may be bred together.
When using the miR-17-92 mouse strain in a publication, please cite the originating article(s) and include JAX stock #008517 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Gt(ROSA)26Sor<tm3(CAG-MIRN17-92,-EGFP)Rsky> |
Frozen Mouse Embryo | C57BL/6-Gt(ROSA)26Sor<tm3(CAG-MIR17-92,-EGFP) Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | C57BL/6-Gt(ROSA)26Sor<tm3(CAG-MIR17-92,-EGFP) Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | C57BL/6-Gt(ROSA)26Sor<tm3(CAG-MIR17-92,-EGFP) Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | C57BL/6-Gt(ROSA)26Sor<tm3(CAG-MIR17-92,-EGFP) Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.